Neuren Pharmaceuticals: Appoints new CEO and Chair following Richard Treagus resignation
- Neuren Pharmaceuticals has appointed Jon Pilcher and Patrick Davies as its Chief Executive Officer and non-executive Chair
- These appointments follow Executive Chairman Richard Treagus decision to leave after over seven years in the role
- Newly appointed CEO, Jon Pilcher, has been the Chief Financial Officer since 2013 and Neuren believes he’s ideal for the new role
- Mr Davies joined the company a little more recently, however, he brings more than 10 years of leadership experience
- Patrick joined the company more recently, in 2018, as the non-executive Director
- Neuren is down a slight 1.19 per cent and shares are trading for $1.66 each
